Liquidia Technologies

• treprostinil

  L606

Sources: clinicaltrials.gov

• United States

Sources: sec.gov

• Founded

  Jan 1, 2004

Sources: wikidata.org

• A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  Phase 3, Recruiting, 344 people, Dec 16, 2025

• Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations

  Phase 1, Completed, 29 people, Dec 6, 2016

Sources: clinicaltrials.gov

• Form D

  $22.4M, Dec 23, 2019

• IPO

  $50M, Jul 25, 2018

• Form D

  $25.5M, Feb 2, 2018

• Series D

  $136K, Feb 1, 2018

• Form D

  $13.8M, Feb 18, 2011

• Form D

  $25M, Jul 1, 2009

Sources: sec.gov, news.google.com